Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis

被引:0
作者
Amir B. Orandi
Vikas R. Dharnidharka
Noor Al-Hammadi
Kevin W. Baszis
机构
[1] Mayo Clinic,Division of Pediatric Rheumatology, Department of Pediatric and Adolescent Medicine
[2] Division of Pediatric Rheumatology,Division of Biostatistics
[3] Department of Pediatrics,undefined
[4] Division of Pediatric Nephrology,undefined
[5] Department of Pediatrics,undefined
[6] Washington University School of Medicine,undefined
来源
Pediatric Rheumatology | / 16卷
关键词
Juvenile dermatomyositis; Calcinosis; Biologics; Pediatric rheumatology;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 169 条
[31]  
Lang B(2013)Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis Medicine (Baltimore) 92 223-undefined
[32]  
LeBlanc CM(2008)The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies Medicine (Baltimore) 87 70-undefined
[33]  
Birdi N(2008)Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity Rheumatology (Oxford) 47 877-undefined
[34]  
Bolaria RK(2017)Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis Pediatr Rheumatol Online J. 15 30-undefined
[35]  
Malleson P(undefined)The new Childhood arthritis and rheumatology research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months undefined undefined undefined-undefined
[36]  
Hoeltzel MF(undefined)undefined undefined undefined undefined-undefined
[37]  
Oberle EJ(undefined)undefined undefined undefined undefined-undefined
[38]  
Robinson AB(undefined)undefined undefined undefined undefined-undefined
[39]  
Agarwal A(undefined)undefined undefined undefined undefined-undefined
[40]  
Rider LG(undefined)undefined undefined undefined undefined-undefined